IPSS for MDS: Survival and AML Evolution
| Prognostic Variable . | Score Value . | ||||
|---|---|---|---|---|---|
| . | 0 . | 0.5 . | 1.0 . | 1.5 . | 2.0 . |
| BM blasts (%) | <5 | 5-10 | — | 11-20 | 21-30 |
| Karyotype3-150 | Good | Intermediate | Poor | ||
| Cytopenias | 0/1 | 2/3 | |||
| Prognostic Variable . | Score Value . | ||||
|---|---|---|---|---|---|
| . | 0 . | 0.5 . | 1.0 . | 1.5 . | 2.0 . |
| BM blasts (%) | <5 | 5-10 | — | 11-20 | 21-30 |
| Karyotype3-150 | Good | Intermediate | Poor | ||
| Cytopenias | 0/1 | 2/3 | |||
Scores for risk groups are as follows: Low, 0; INT-1, 0.5-1.0; INT-2, 1.5-2.0; and High, ≥2.5.
Good, normal, −Y, del(5q), del(20q); Poor, complex (≥3 abnormalities) or chromosome 7 anomalies; Intermediate, other abnormalities.